Novo Nordisk Confident as Ozempic, Wegovy Demand Continues

May 2, 2024 | Uncategorized

The Danish pharmaceutical giant raised its full-year guidance to reflect better pricing in the U.S. and as global demand for its weight-loss and diabetes drugs continued to outstrip supply.

Translate »
Contactar
1
Scan the code
Hola👋
¿Cómo podemos ayudarte?